Journal of Traditional Chinese Medicine >
A prognostic model of immunoglobulin A nephropathy using artificial neural network: a retrospective study based on integrated Chinese and Western Medicine
Received date: 2024-01-12
Accepted date: 2024-05-15
Online published: 2025-05-21
Supported by
Natural Science Foundation-funded Project: Study on the Mechanism of Compound Centella Asiatica Mediate 24‐dehydrocholesterol Reductase/Liver X Receptors (DHCR24/LXR) Signaling Axis to Regulate Macrophage Activation and Alleviate Microinflammation in Diabetic Kidney Disease(82205008);Medical Scientific Research Foundation of Zhejiang Province: Study on the Mechanism of Asiaticoside Mediate DHCR24/LXR Signaling Axis to Regulate Macrophage Innate Immune Response in Diabetic Kidney Disease(2023RC242);Zhejiang Traditional Medicine and Technology Program: Chen Hongyu's Academic Thought and Clinical Experience in the Diagnosis and Treatment of Diabetic Nephropathy by Knowledge Map(2023ZF137);Health Commission of Hangzhou city: Study on Prognosis Model of IgA Nephropathy Combined with Chinese and Western Medicine based on Artificial Neural Network(A20210083);Zhejiang Chinese Medical University Research Foundation: Study on Wang Yongjun's Clinical Decision Model for Diagnosis and Treatment of Diabetic Nephropathy based on Graph Convolutional Neural Network(2022FSYYZZ14)
OBJECTIVE: To establish and evaluate a prognostic model of immunoglobulin A nephropathy (IgAN) based on integrated Chinese and Western Medicine.
METHODS: Retrospective analysis from 1/1/2013 to 12/31/2015 was performed on 735 patients who were diagnosed with IgAN. In addition, 105 external data sets from 1/1/2016 to 12/31/2018 were used to verify the constructed model. The end point was entry into end-stage renal disease or a doubling of serum creatinine (Scr) level from baseline. Kaplan-Meier curve survival analysis and multivariable Cox regression analysis were used to find independent prognostic factors. MATLAB 2018b and artificial neural network (ANN) were used to construct prognostic risk factor prediction models each for Traditional Chinese Medicine (TCM), Western Medicine, and integrated TCM and Western Medicine. The ANN model incorporated WANG Yongjun's new five-type syndrome differentiation for IgAN. The prediction efficiencies of the three models were compared using the confusion matrix and the area under thecurve (AUC).
RESULTS: Patients from 1/1/2013 to 12/31/2015 were followed for a mean of (46 ± 19) months. The 5-year median overall renal survival time was 58.6 months, and a total of 40 patients (5.4%) entered the endpoint. Ratio of males to females was 1.48:1. Median age of patients undergoing renal puncture was 35 years. Median 24-hour urinary protein was 0.55 g and 37 patients (5.0%) had pronounced proteinuria (24-hour urine protein ≥ 3.5 g). Median serum creatinine was 76 μmol/L and mean estimated glomerular filtration rate was (90 ± 33) mL/min per 1.73 m2. Oxford classification of renal pathology suggested a high rate of focal segmental glomeru-losclerosis (80.3%). Use of immunosuppressants was the most common (71.3%) treatment after renal puncture and improved clinical outcomes of IgAN. TCM differentiation of kidney deficiency was the most common syndrome (69.5%). Independent risk factors for the endpoint were male, anemia, high urinary protein, and an Oxford classification of segmental sclerosis (S). AUCs of the Western Medicine, TCM, and integrated Chinese and Western Medicine models were 0.89, 0.87, and 0.92, respectively. In external data (1/1/2016 to 12/31/2018), the performance of the three models was 0.88, 0.80, and 0.94, respectively.
CONCLUSIONS: ANN can be used to successfully construct a 5-year prediction model of IgAN after renal puncture. The efficiency of this model, which combines TCM and Western Medicine factors based on Wang’s new five-type syndrome differentiation, exceeds that of Western Medicine factors or TCM factors alone in data from this single-center retrospective study.
Hongyu CHEN , Xinyi ZHENG , Zeng WANG , Xiaoyu DING , Luhuan XU , Qin ZHU . A prognostic model of immunoglobulin A nephropathy using artificial neural network: a retrospective study based on integrated Chinese and Western Medicine[J]. Journal of Traditional Chinese Medicine, 2025 , 45(3) : 676 -684 . DOI: 10.19852/j.cnki.jtcm.2025.03.002
| 1. | Rodrigues JC, Haas M, Reich HN. IgA nephropathy. Clin J Am Soc Nephrol 2017; 12: 677-86. |
| 2. | Kamano C, Shimizu A, Joh K, et al. A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study. Clin Exp Nephrol 2021; 25: 509-21. |
| 3. | Barbour SJ, Espino-Hernandez G, Reich HN, et al. The MEST score provides earlier risk prediction in IgA nephropathy. Kidney Int 2016; 89: 167-75. |
| 4. | Barbour SJ, Cattran DC, Kim SJ, et al. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Kidney Int 2013; 84: 1017-24. |
| 5. | Ganzer PD, Loeian MS, Roof SR, et al. Dynamic detection and reversal of myocardial ischemia using an artificially intelligent bioelectronic medicine. Sci Adv 2022; 8: eabj5473. |
| 6. | Wang Y, Chen H, Zhu C, et al. Study on syndrome-manifestation of Traditional Chinese Medicine in 1148 patients with IgA nephropathy. Zhong Xi Yi Jie He Shen Bing Za Zhi 2009; 12: 1054-58. |
| 7. | World Health Organization.ICD-11: International classification of diseases (11th revision) online, 2019-05-25, cited 2021-8-02; 1(1): 3screens. Available from URL: https://www.who.int/news-room/detail/25-05-2019-world-health-assembly-update. |
| 8. | State Bureau of Technology Supervision. National standard for clinical terms of Traditional Chinese Medicine: GB/T 16751.2-1997. Beijing: China Standard Press:1-358. |
| 9. | Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70. |
| 10. | Kidney Disease: Improving Global Outcomes KDIGO Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 2021; 100: S1-S276. |
| 11. | Trimarchi H, Barratt J, Cattran DC, et al. IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Conference Participants. Oxford classification of IgA nephropathy 2016:an update from the IgA Nephropathy Classification Working Group. Kidney Int 2017; 91: 1014-21. |
| 12. | Deng W, Tan X, Zhou Q, et al. Gender-related differences in clinicopathological characteristics and renal outcomes of Chinese patients with IgA nephropathy. BMC Nephrol 2018; 19: 31. |
| 13. | Shu D, Xu F, Su Z, et al. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study. BMC Nephrol 2017; 18: 1-6. |
| 14. | Chen T, Xia E, Chen T, et al. Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy. EBioMedicine 2020; 52: 102657. |
| 15. | Tan J, Xu Y, Jiang Z, et al. Global glomerulosclerosis and segmental glomerulosclerosis could serve as effective markers for prognosis and treatment of IgA vasculitis with nephritis. Front Med (Lausanne) 2020; 7: 588031. |
| 16. | Shen X. Research on renal histopathological characteristics, clinical manifestations, treatment and prognosis of IgAN. Nanjing: Nanjing University, 2014: 11-39. |
| 17. | Markowitz G. Updated Oxford classification of IgA nephropathy: a new MEST-C score. Nat Rev Nephrol 2017; 13: 385-86. |
| 18. | Goto M, Kawamura T, Wakai K, et al. Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm. Nephrol Dial Transplant 2009; 24: 1242-47. |
| 19. | Gu YH. A prognostic model of IgAN based on clinicopathological features and TCM syndromes. Guangzhou: Guangzhou University of Chinese Medicine, 2017: 27-93. |
| 20. | Liu J. Research on prognostic evaluation models of IgA nephropathy. Beijing: Chinese People's Liberation Army (PLA) Medical School, 2018: 35-88. |
| 21. | Lee HS, Koh HI, Lee HB, Park HC. IgA nephropathy in Korea: a morphological and clinical study. Clin Nephrol 1987; 27: 131-40. |
| 22. | Chen T, Li X, Li Y, et al. Prediction and risk stratification of kidney outcomes in IgA nephropathy. Am J Kidney Dis 2019; 74: 300-09. |
| 23. | Chen XM, Chen Y, Li P, et al. A multicenter epidemiological survey on TCM syndrome in 1016 patients with IgA nephropathy and analysis of its relevant factors. Zhong Xi Yi Jie He Za Zhi 2006; 26: 197-97. |
| 24. | Wang YJ, Chen HY, Zhou LS, et al. Study on the therapy based on tonifying deficiency, resolving blood stasis and dispelling wind-dampness of IgA nephropathy in 123 cases. Zhong Xi Yi Jie He Shen Bing Za Zhi 2008; 9: 879-79. |
/
| 〈 |
|
〉 |